WEEKLY EXECUTIVE SUMMARY · AUGUST 26, 2026
Your seven-day briefing on kratom news, state regulation and federal scheduling — written for adults who buy natural-leaf kratom powder and capsules.
This week in kratom news, the story moved decisively to the states. Massachusetts became the largest state in years to place every form of the leaf into Schedule I under state law, with the order taking effect this Friday. North Dakota’s statewide emergency prohibition has now been in force for three weeks and heads to a special legislative session on September 2. Meanwhile, the federal action everyone has been watching — the DEA’s temporary Schedule I order for concentrated and synthetic 7-hydroxymitragynine (7-OH) — still has not appeared in the Federal Register, three weeks after the earliest date it could have published. Below is the full roundup, plus what it does and does not mean for natural-leaf powder and capsules.
TABLE OF CONTENTS
1. Kratom News at a Glance: August 20–26, 2026
2. Massachusetts Schedules All Kratom, Effective August 28
3. North Dakota’s Emergency Ban and the September 2 Special Session
4. DEA’s 7-OH Order Still Has Not Published
5. New Research: 17 Kratom Alkaloids Measured in Human Plasma
6. What This Week Means for Natural-Leaf Buyers
1. Kratom News at a Glance: August 20–26, 2026
The through-line in this week’s kratom news is a widening gap between state and federal action. While Washington has been slow to finalize its narrow, chemistry-based rule aimed at concentrated 7-OH, individual states are moving far faster and far more broadly — several of them sweeping ordinary leaf material into the same category as laboratory-modified products. That distinction matters enormously to anyone who buys plain, unadulterated powder or capsules, and it is worth understanding precisely.
2. Massachusetts Schedules All Kratom, Effective August 28
On August 13, Governor Maura Healey announced that Department of Public Health Commissioner Robbie Goldstein, MD, PhD, had issued an emergency order temporarily placing all forms of kratom into Schedule I under Massachusetts law. Per the state’s own press release, the order takes effect following a 14-day notice period — which lands on Friday, August 28, 2026 — and remains in effect for up to one year.
What the order actually does
The order’s practical effect is to give local boards of health and municipal officials additional authority to take enforcement action against retailers selling kratom products. Massachusetts officials framed the problem as one of an unregulated retail channel: the state noted that kratom is widely sold in smoke shops, convenience stores and gas stations as powders, tablets, capsules, gummies and dissolvable strips, and that products vary significantly in potency and ingredients, making it difficult for consumers to know what they are purchasing.
Alongside the scheduling action, DPH launched a consumer resource page at mass.gov/kratom, is briefing local boards of health, health care providers and substance use treatment programs, and is holding an implementation webinar for local public health officials. The Massachusetts Chiefs of Police Association, the Massachusetts Association of Health Boards, and police chiefs in Arlington and Brockton issued statements backing the move, with an emphasis on youth access and on products sold legally off a store shelf whose contents and potency buyers could not verify.
Why this one is different
Most 2026 state activity has been narrowly targeted at concentrated and chemically modified 7-OH products. The Massachusetts order is not narrow. It covers the plant material itself, not just enhanced extracts, and it was issued through emergency administrative authority rather than through the legislature. That is the same broad approach North Dakota took earlier in the month, and it is the pattern advocates for a Kratom Consumer Protection Act framework have spent years arguing against — their position being that age limits, labeling requirements, contaminant testing and adulteration bans regulate the retail problem more precisely than prohibition does. For a fuller state-by-state picture and ongoing coverage, see the latest kratom news and our own 2026 kratom legality guide.
3. North Dakota’s Emergency Ban and the September 2 Special Session
North Dakota moved first and moved hardest. On August 3, Governor Kelly Armstrong and Attorney General Drew Wrigley announced a package of executive actions banning kratom statewide. Armstrong issued an executive order declaring a public health emergency and prohibiting the sale, use and possession of all kratom and kratom products in North Dakota, effective 5 p.m. on Wednesday, August 5. Separately, the North Dakota Board of Pharmacy issued an emergency rule classifying 7-hydroxymitragynine as a Schedule I controlled substance under state law.
The state cited its own mortality and poison-center data in support: from 2019 through June 2026, kratom and related substances were part of the primary cause of death for 23 people in North Dakota, and kratom-related calls to Poison Control in the state rose from seven in 2024 to 22 the following year.
The date to watch is September 2. Armstrong has called a special legislative session for that day to write the prohibition into state law and to sort out enforcement authority — an executive order declaring an emergency is a blunt instrument with a short shelf life, and codification is where the details (possession penalties, retailer liability, whether any exemption exists for plain leaf) will actually get argued. Anyone tracking kratom news should treat that session as the most consequential state calendar item of early September.
4. DEA’s 7-OH Order Still Has Not Published
The federal timeline, for anyone joining late: the DEA issued notices of intent on July 1 to temporarily control 7-OH and three related synthetic substances — mitragynine pseudoindoxyl, MGM-15 and MGM-16 — in Schedule I. Those notices published in the Federal Register on July 6. Statute requires a 30-day notice period, which meant the temporary scheduling order could issue at any point on or after August 5, 2026.
As of this writing on August 26, that order still has not published. Three weeks have now passed since the window opened. The order becomes effective on the date it publishes, not on some later date, so there is no advance warning built into the process — whenever it lands, the covered substances become Schedule I the same day, with control lasting two years and a possible one-year extension.
The threshold that keeps natural leaf out
The single most important technical detail — and the one most often garbled in mainstream coverage — is the threshold. The proposed control applies to material containing more than 0.05% 7-OH by dry weight. That figure was chosen specifically to capture manufactured, concentrated and synthetic products while leaving ordinary botanical leaf below the line. Naturally occurring 7-OH in unadulterated Mitragyna speciosa leaf sits well under that threshold; it is a trace alkaloid, not a headline one. Neither the leaf itself nor mitragynine is named in the DEA notices.
In plain terms: the federal action is a chemistry rule aimed at a category of products that were engineered to be far stronger than the plant they were derived from. Plain powder and plain capsules are not the target. That is worth stating clearly, because the state-level actions described above do not follow the same logic — Massachusetts and North Dakota both went broader than the federal proposal, which is precisely why a product can be federally uncontrolled and locally illegal at the same time.
5. New Research: 17 Kratom Alkaloids Measured in Human Plasma
On August 17, researchers from the University of Florida and Johns Hopkins University published a study in Pharmaceutical Biology describing the simultaneous quantification of seventeen kratom alkaloids and metabolites in human plasma, applied to clinical pharmacokinetic sample analysis. The team developed a laboratory method capable of measuring twelve alkaloids and five mitragynine metabolites at once, then applied it to blood samples from four adults who use kratom regularly.
This is not a safety finding or an efficacy finding, and it should not be reported as one. Its contribution is analytical. Until now, most human studies have tracked one or two markers, which meant regulators, toxicologists and researchers were reasoning about a chemically complex plant from a very narrow window. A validated multi-analyte assay is the sort of unglamorous infrastructure that makes better-designed clinical and forensic work possible — including, eventually, the kind of evidence base that policy arguments on both sides keep claiming to have. Four subjects is a method-validation sample, not a population study, and no conclusions about outcomes follow from it.
It also lands at a useful moment. Several researchers have argued publicly this summer that “kratom” has become an unhelpfully broad label covering everything from traditional leaf to synthetic derivatives with entirely different pharmacology. Tools that can actually distinguish what is in a person’s bloodstream are a prerequisite for policy that distinguishes between those categories.
6. What This Week Means for Natural-Leaf Buyers
Three practical takeaways from this week’s kratom news, none of which involve any health claim:
Check your own state before you order
This is now the single most important step for any buyer. Massachusetts and North Dakota residents are subject to state prohibitions regardless of what the federal government does or does not do. County and municipal ordinances add another layer in several states. Legal status in 2026 is genuinely a moving target, and a vendor cannot make that determination for you. KratomWorld.com does not ship where prohibited, and all sales are restricted to adults 21 and over.
Know the difference between leaf and concentrate
Nearly every enforcement action of the past eighteen months — federal warning letters, the DEA notices, the state pharmacy-board rules, the tablet-product investigations — has centered on concentrated, enhanced or laboratory-modified material, frequently sold in gas stations under branding that never used the word kratom at all. Plain milled leaf sold as powder or in capsules is a different product category with a different regulatory posture. Knowing which one you are holding is the whole ballgame.
Buy from vendors who publish their testing
The recurring complaint in every one of this week’s government statements is that consumers could not verify what was in the product. That is an argument for third-party lab testing, clear labeling and GMP-standard handling — which is what a serious natural-leaf vendor should be offering regardless of what any regulator requires. See our guide to GMP certification and what it actually covers.
7. Shop Lab-Tested Natural-Leaf Powder & Capsules
KratomWorld.com sells single-strain, natural-leaf kratom powder and capsules — no concentrates, no synthetic 7-OH, no enhanced blends. Adults 21+ only, where legal.
Red Maeng Da Kratom
From $14.95
Our most-ordered red vein. Finely milled natural leaf, available in powder and capsules, sized from starter pouches up to full kilos.
Green Maeng Da Kratom
From $14.99
The green-vein counterpart to our best seller. Single-strain natural leaf, third-party tested, powder or capsules.
Red Bali Kratom
From $14.95
A classic red-vein leaf and one of the most recognizable strains on the market. Natural leaf only — no extracts, no additives.
5 Kilo Bulk Kratom Powder
From $249.95
Mix and match any five kilos of natural-leaf powder at our lowest per-kilo pricing. Built for regular buyers and small retailers.
8. Kratom News FAQ
When does the Massachusetts kratom ban take effect?
The Massachusetts Department of Public Health emergency order was announced on August 13, 2026 and takes effect after a 14-day notice period, which lands on August 28, 2026. It places all forms of kratom into Schedule I under state law and remains in effect for up to one year.
Has the DEA officially banned 7-OH yet?
Not as of August 26, 2026. The DEA filed notices of intent on July 1 that published in the Federal Register on July 6, and the earliest the temporary Schedule I order could issue was August 5. Three weeks later the order still has not appeared. When it does publish, it takes effect that same day.
Does the DEA’s 7-OH action cover natural kratom leaf?
The proposed threshold is 0.05% 7-OH by dry weight, which was set to capture concentrated and synthetic products while leaving ordinary botanical leaf below the line. Neither kratom leaf nor mitragynine is named in the notices. State laws, however, can and do go broader — Massachusetts and North Dakota both cover the leaf itself.
What is happening in North Dakota on September 2?
Governor Kelly Armstrong has called a special legislative session for September 2, 2026 to write his emergency statewide kratom prohibition into state law and to address enforcement authority. The executive order banning sale, use and possession took effect at 5 p.m. on August 5.
How do I check whether kratom is legal where I live?
Check your state statute or health department first, then your county and city ordinances, since local prohibitions exist in several otherwise-legal states. Status changed in multiple jurisdictions during 2026, so verify before every order rather than relying on a page you read months ago.